                         SEQUENCE LISTING

<110>  Pfizer Inc.
       Collins, Michael
       Critcher, Douglas
       Desrosiers, Jean-Nicolas
       Karmilowicz, Michael
       Martinez, Carlos
       Ragan, John
       Sutton, Scott
 
<120>  SYNTHESIS OF NOVEL INTERMEDIATES FOR SUBSTITUTED 
       3,4-DIHYDROISOQUINOLINONES

<130>  PC072546A

<150>  63/053,957
<151>  2020-07-20

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  343
<212>  PRT
<213>  Sporobolomyces salmonicolor

<400>  1

Met Ala Lys Ile Asp Asn Ala Val Leu Pro Glu Gly Ser Leu Val Leu 
1               5                   10                  15      


Val Thr Gly Ala Asn Gly Phe Val Ala Ser His Val Val Glu Gln Leu 
            20                  25                  30          


Leu Glu His Gly Tyr Lys Val Arg Gly Thr Ala Arg Ser Ala Ser Lys 
        35                  40                  45              


Leu Ala Asn Leu Gln Lys Arg Trp Asp Ala Lys Tyr Pro Gly Arg Phe 
    50                  55                  60                  


Glu Thr Ala Val Val Glu Asp Met Leu Lys Gln Gly Ala Tyr Asp Glu 
65                  70                  75                  80  


Val Ile Lys Gly Ala Ala Gly Val Ala His Ile Ala Ser Val Val Ser 
                85                  90                  95      


Phe Ser Asn Lys Tyr Asp Glu Val Val Thr Pro Ala Ile Gly Gly Thr 
            100                 105                 110         


Leu Asn Ala Leu Arg Ala Ala Ala Ala Thr Pro Ser Val Lys Arg Phe 
        115                 120                 125             


Val Leu Thr Ser Ser Thr Val Ser Ala Leu Ile Pro Lys Pro Asn Val 
    130                 135                 140                 


Glu Gly Ile Tyr Leu Asp Glu Lys Ser Trp Asn Leu Glu Ser Ile Asp 
145                 150                 155                 160 


Lys Ala Lys Thr Leu Pro Glu Ser Asp Pro Gln Lys Ser Leu Trp Val 
                165                 170                 175     


Tyr Ala Ala Ser Lys Thr Glu Ala Glu Leu Ala Ala Trp Lys Phe Met 
            180                 185                 190         


Asp Glu Asn Lys Pro His Phe Thr Leu Asn Ala Val Leu Pro Asn Tyr 
        195                 200                 205             


Thr Ile Gly Thr Ile Phe Asp Pro Glu Thr Gln Ser Gly Ser Thr Ser 
    210                 215                 220                 


Gly Leu Met Met Ser Leu Phe Asn Gly Glu Val Ser Pro Ala Leu Ala 
225                 230                 235                 240 


Leu Met Pro Pro Cys Tyr Tyr Val Ser Ala Val Asp Ile Gly Leu Leu 
                245                 250                 255     


His Leu Gly Cys Leu Val Leu Pro Gln Ile Glu Arg Arg Arg Val Tyr 
            260                 265                 270         


Gly Thr Ala Gly Thr Phe Asp Trp Asn Thr Val Leu Ala Thr Phe Arg 
        275                 280                 285             


Lys Leu Tyr Pro Ser Lys Thr Phe Pro Ala Asp Phe Pro Asp Gln Gly 
    290                 295                 300                 


Gln Asp Leu Ser Lys Phe Asp Thr Ala Pro Ser Leu Glu Ile Leu Lys 
305                 310                 315                 320 


Ser Leu Gly Arg Pro Gly Trp Arg Ser Ile Glu Glu Ser Ile Lys Asp 
                325                 330                 335     


Leu Val Gly Ser Glu Thr Ala 
            340             


